These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 31384519)
1. The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. Jasirwan COM; Lesmana CRA; Hasan I; Sulaiman AS; Gani RA Biosci Microbiota Food Health; 2019; 38(3):81-88. PubMed ID: 31384519 [TBL] [Abstract][Full Text] [Related]
2. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms. Bakhshimoghaddam F; Alizadeh M Clin Nutr ESPEN; 2021 Aug; 44():61-68. PubMed ID: 34330514 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642 [TBL] [Abstract][Full Text] [Related]
4. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? Xie C; Halegoua-DeMarzio D Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378 [TBL] [Abstract][Full Text] [Related]
5. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Wang T; Ishikawa T; Sasaki M; Chiba T Front Med (Lausanne); 2022; 9():822190. PubMed ID: 35308549 [TBL] [Abstract][Full Text] [Related]
6. Obesity, fatty liver disease and intestinal microbiota. Arslan N World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013 [TBL] [Abstract][Full Text] [Related]
7. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Jennison E; Byrne CD Clin Mol Hepatol; 2021 Jan; 27(1):22-43. PubMed ID: 33291863 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Suk KT; Kim DJ Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367 [TBL] [Abstract][Full Text] [Related]
10. The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. Jia W; Rajani C Adv Exp Med Biol; 2018; 1061():95-110. PubMed ID: 29956209 [TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Hrncir T; Hrncirova L; Kverka M; Hromadka R; Machova V; Trckova E; Kostovcikova K; Kralickova P; Krejsek J; Tlaskalova-Hogenova H Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946843 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and non-alcoholic fatty liver disease. Gkolfakis P; Dimitriadis G; Triantafyllou K Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):572-81. PubMed ID: 26663004 [TBL] [Abstract][Full Text] [Related]
14. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis. Han H; Jiang Y; Wang M; Melaku M; Liu L; Zhao Y; Everaert N; Yi B; Zhang H Crit Rev Food Sci Nutr; 2023; 63(12):1689-1706. PubMed ID: 34404276 [TBL] [Abstract][Full Text] [Related]
15. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease. Koukias N; Buzzetti E; Tsochatzis EA Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962 [TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Ma J; Zhou Q; Li H Nutrients; 2017 Oct; 9(10):. PubMed ID: 29035308 [TBL] [Abstract][Full Text] [Related]
18. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Tokuhara D Front Nutr; 2021; 8():700058. PubMed ID: 34250000 [TBL] [Abstract][Full Text] [Related]
19. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer. Ezzaidi N; Zhang X; Coker OO; Yu J Cancer Lett; 2019 Sep; 459():186-191. PubMed ID: 31185249 [TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota: Association with NAFLD and Metabolic Disturbances. Lau E; Carvalho D; Freitas P Biomed Res Int; 2015; 2015():979515. PubMed ID: 26090468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]